Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.

Changing the way antibiotics are developed and accessed.

A public-health driven model to tackle AMR.

Our latest news and resources.

Protecting people from the rise and spread of drug-resistant infections.

Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.

Our funders.

Thank you for helping us develop next-generation antibiotics for all.

We thank every GARDP funder for their financial contribution and for prioritizing public health needs. With your essential and unwavering support, we are developing antibiotic treatments to protect people from the rise and spread of antimicrobial resistance.

Please join us in advancing our vision of a world where everyone has access to next-generation antibiotics to treat drug-resistant infections. 

Our funders

Public funders

Private funders

“GARDP’s non-profit, public-private approach is important to developing new treatments for drug-resistant bacteria. By working with GARDP, the Japanese government has been able to build trust with international partners to address this issue of global concern.”

Ms Akiko Honda, Member of House of Councillors, the National Diet of Japan

“We are at a pivotal moment in the global fight against antimicrobial resistance, and international collaboration is more important than ever. The UK is proud to continue this partnership with GARDP, driving life-saving innovations such as the first new antibiotic for drug-resistant gonorrhoea in over 30 years. We remain committed to working with GARDP to ensure that these vital treatments reach those who need them most around the world.”

Dame Sally Davies, UK Special Envoy for AMR

The time to act is now –

make an impact

Support us